Gonadorelin - Hormonal & Sexual Health
Contraindications: This peptide has 5 known contraindication(s). See Safety section
Hormonal & Sexual HealthModerate

Gonadorelin

Also known as: GnRH, LHRH, Gonadotropin-Releasing Hormone, Luteinizing Hormone-Releasing Hormone, Factrel, Lutrepulse

Controlled Substance
FDA Approved
MW: 1182.29 g/mol • 44 amino acids

A synthetic form of gonadotropin-releasing hormone (GnRH) used to stimulate the release of FSH and LH from the pituitary, supporting natural testosterone production and fertility in both men and women.

â–¶ Gonadorelin in 30 Seconds

Research overview only. Not medical advice.

Half-Life

2-4 minutes

Typical Dose

50-200 mcg

Frequency

1-3x daily or pulsatile

Routes

Subcutaneous

Half-Life Visualization

Comparing 1 peptide. Gonadorelin has a half-life of 0.05h, reaching 50% concentration at 0.05h and 25% at 0.1h.

Half-Life Decay Curve

Concentration over time assuming initial dose = 100%

Gonadorelin(t1/2: 0.05h +/- 0.020000000000000004h)
Peptide Half-Life Comparison ChartVisualization showing how peptide concentrations decay over time. Gonadorelin has a half-life of 0.05h.

Use arrow keys to navigate: Left/Right for time, Up/Down for peptides

Shaded areas represent reported half-life variability from published studies.

PeptideHalf-Life50% at25% at12.5% atRedose Window
Gonadorelin
0.05h0.05h0.1h0.15000000000000002h0.05h - 0.1h

Showing Gonadorelin decay curve

Open Full Comparison Tool

Mechanism of Action

Gonadorelin is a synthetic decapeptide identical to endogenous gonadotropin-releasing hormone (GnRH), also known as luteinizing hormone-releasing hormone (LHRH). It is the master regulator of the hypothalamic-pituitary-gonadal (HPG) axis.

Primary Mechanism

Pituitary Stimulation

When administered in pulsatile fashion:

  • Binds to GnRH receptors on pituitary gonadotroph cells
  • Triggers release of Luteinizing Hormone (LH)
  • Triggers release of Follicle-Stimulating Hormone (FSH)
  • Maintains natural feedback mechanisms

Downstream Effects

In males:

  • LH stimulates Leydig cells to produce testosterone
  • FSH supports spermatogenesis via Sertoli cells
  • Preserves testicular function and fertility

In females:

  • LH triggers ovulation and corpus luteum formation
  • FSH stimulates follicular development
  • Supports natural menstrual cycle regulation

Pulsatile vs Continuous Administration

Critical distinction:

  • Pulsatile: Mimics natural hypothalamic secretion; stimulates gonadotropin release
  • Continuous: Causes receptor downregulation and desensitization; eventually suppresses axis

This is why timing and dosing pattern are essential for desired outcomes.

Comparison to GnRH Agonists

FeatureGonadorelinLong-Acting GnRH Agonists
Half-lifeMinutesDays to months (depot)
Initial effectStimulationFlare then suppression
Long-term effectMaintains axisSuppresses axis
Use in TRTPreserve fertilityProstate cancer

Research & Evidence

Evidence Level: Gonadorelin has extensive clinical research and FDA approval for diagnostic and therapeutic use. It is one of the most well-studied reproductive peptides.

Fertility Treatment

Hypogonadotropic Hypogonadism

Pulsatile gonadorelin therapy:

  • Restores normal pulsatile LH/FSH secretion
  • Induces spermatogenesis in men
  • Induces ovulation in women
  • More physiological than gonadotropin injections

Male Fertility Preservation

During testosterone replacement:

  • Maintains intratesticular testosterone
  • Preserves spermatogenesis
  • Alternative to HCG for testicular support
  • May maintain testicular volume

Testosterone Restoration

Post-Cycle Recovery

After anabolic steroid use:

  • Helps restart natural testosterone production
  • Part of comprehensive PCT protocols
  • Used alongside SERMs and HCG
  • Supports HPT axis recovery

Age-Related Decline

Research explores:

  • Stimulating endogenous testosterone
  • Alternative to TRT in mild hypogonadism
  • Preserving natural axis function

Diagnostic Use

FDA-approved indications:

  • Evaluating pituitary function
  • Distinguishing hypothalamic vs pituitary hypogonadism
  • Assessing gonadotropin reserve
  • Timing of puberty onset

Female Applications

Fertility medicine uses:

  • Ovulation induction in hypothalamic amenorrhea
  • Support for IVF protocols
  • Treatment of PCOS-related infertility
  • More physiological than gonadotropin injections

Dosing

Disclaimer: Gonadorelin is a prescription medication. Use should be supervised by a qualified healthcare provider. Dosing information is for educational reference.

Research Protocols

Administration Methods

Subcutaneous (Most Common)

  • Standard route for clinical use
  • Rapid absorption
  • Can be self-administered
  • Preferred for regular dosing

Pulsatile Pump Delivery

  • Mimics natural hypothalamic secretion
  • Delivers pulses every 60-120 minutes
  • Most physiological approach
  • Used in fertility clinics

Timing Considerations

  • Space doses throughout the day
  • Avoid continuous infusion (causes suppression)
  • Morning and evening dosing commonly used
  • Can be combined with other fertility agents

Reconstitution

When using lyophilized powder:

  • Reconstitute with bacteriostatic water or saline
  • Typical concentration varies by protocol
  • Refrigerate after reconstitution
  • Use within 7-14 days

Pharmacokinetics

Absorption

  • IV: Immediate, 100% bioavailable
  • SC/IM: Rapid, peak within minutes
  • Very short duration of action
  • Requires frequent dosing for therapeutic effect

Distribution

  • Rapid distribution to target tissues
  • Reaches pituitary quickly
  • Short circulation time
  • Minimal tissue accumulation

Metabolism

  • Rapidly degraded by peptidases
  • Half-life of only 2-4 minutes
  • Metabolized in blood, liver, and kidneys
  • No active metabolites

Elimination

  • Half-life: 2-4 minutes (very short)
  • Rapid clearance requires pulsatile delivery
  • Eliminated primarily via enzymatic degradation
  • No accumulation with pulsatile dosing

Synergy & Stacking

Gonadorelin + HCG

Dual stimulation approach:

  • Gonadorelin: Pituitary LH stimulation
  • HCG: Direct testicular LH-receptor activation
  • Provides redundant signaling pathways
  • May be used alternating or in sequence

Gonadorelin + Kisspeptin-10

Upstream and direct stimulation:

  • Kisspeptin stimulates endogenous GnRH release
  • Gonadorelin provides direct GnRH receptor activation
  • Amplified pituitary response
  • Research protocol combination

Gonadorelin + SERM (Clomiphene/Enclomiphene)

Fertility optimization:

  • SERM blocks estrogen negative feedback
  • Gonadorelin provides pulsatile stimulation
  • Synergistic increase in LH/FSH
  • Common in male fertility protocols

PCT Stack

Post-cycle recovery:

  • Gonadorelin for axis stimulation
  • HCG for testicular support
  • SERM for estrogen modulation
  • Comprehensive recovery approach

Safety & Side Effects

Known Side Effects

Common

  • Headache
  • Flushing
  • Nausea
  • Injection site reactions

Uncommon

  • Dizziness
  • Abdominal discomfort
  • Light-headedness

In Fertility Treatment

  • Ovarian hyperstimulation syndrome (women)
  • Multiple pregnancy risk
  • Mood changes

Serious Risks

Tumor Considerations

  • Initial hormone surge may stimulate hormone-sensitive tumors
  • Pituitary apoplexy risk with pituitary adenomas
  • Requires proper medical evaluation before use

Warning: Gonadorelin should not be used in pregnancy. It can cause fetal harm. Reliable contraception required during treatment cycles.

Long-term Considerations

  • No significant long-term adverse effects documented with proper use
  • Pulsatile administration maintains axis function
  • Continuous administration causes desensitization
  • Regular monitoring recommended

Monitoring

Baseline Testing

Before starting treatment:

  • Testosterone levels (total and free)
  • LH and FSH levels
  • Estradiol
  • Semen analysis (fertility cases)
  • Pituitary function evaluation
  • Rule out contraindications

During Treatment

Regular monitoring of:

  • Hormone levels (LH, FSH, testosterone)
  • Response to stimulation
  • Side effects
  • Testicular examination (males)
  • Ovarian response (females)

Follow-up

  • Periodic hormone panels
  • Fertility parameters as appropriate
  • Adjust dosing based on response
  • Evaluate need for continued treatment

Regulatory Status

Current Status

RegionStatus
United StatesFDA-approved (Rx only)
CanadaPrescription medication
European UnionApproved prescription
United KingdomPrescription only
AustraliaSchedule 4 (Rx)
WADAProhibited in sport

Approved Uses

FDA-approved indications:

  • Diagnostic testing of pituitary function
  • Treatment of hypogonadotropic hypogonadism
  • Infertility treatment
  • Research applications

Legal Considerations

  • Prescription required in most jurisdictions
  • Prohibited in competitive sports (WADA banned)
  • Used off-label in TRT and PCT settings
  • Legitimate medical uses are well-established

References

[] Conn PM, Crowley WF Jr.. Gonadotropin-releasing hormone and its analogs. Annual Review of Medicine () doi:10.1146/annurev.med.45.1.391
[] Santen RJ, Bardin CW.. Episodic luteinizing hormone secretion in man. Journal of Clinical Investigation () doi:10.1172/JCI107327
[] Schally AV.. LH-RH analogues: I. Their impact on reproductive medicine. Gynecological Endocrinology () doi:10.3109/09513599909167350
[] Hayes FJ, et al.. Use of a gonadotropin-releasing hormone antagonist as a physiologic probe in polycystic ovary syndrome. Journal of Clinical Endocrinology & Metabolism () doi:10.1210/jcem.83.7.4920
[] Reproductive Endocrinology Review. GnRH Pulsatile Therapy: Applications in Male and Female Infertility. Fertility and Sterility ()

Compare Gonadorelin Prices

1 vendor
VendorQuantityPrice$/mg
Core PeptidesBest Value
10mg$90.00$9.00/mgView Deal

For research purposes only. We may earn a commission.

See all vendors →

Community Insights

Limited Data

Aggregated from 14 self-reported experiences collected from public forums.

Overall Sentiment

Neutral(-0.06)
21.4% positive42.9% neutral35.7% negative

Reported Benefits

  • felt the best i've ever felt in my adult life1x
  • healthy markers1x
  • helped achieve weight loss goals1x

Reported Side Effects

  • mental state crashes1x
  • energy depletion1x
  • tiredness1x
  • anxiety1x
  • depression1x
  • difficulty focusing1x

Common Doses Reported

  • 0.1mg 2x/week1 report
  • 1mg1 report
  • 50mg twice per week1 report
  • 500mcg1 report
  • 2 times a week1 report

Administration Routes

  • oral1 report
  • sublingual1 report
  • subcutaneous1 report
  • intramuscular1 report

This data reflects self-reported user experiences collected from public forums. It is not medical advice. Individual results vary. Always consult a qualified healthcare professional before using any research compound.

Get Our Free Peptide Research Guide

100 essential tips for safe peptide research, delivered as a free PDF.

Where to Buy Gonadorelin

Compare prices from 1 vendor • Best value: $9.00/mg

Full Comparison
Core Peptides

10

$90.00

$9.00/mg

Disclaimer: These products are sold for research purposes only. Prices and availability may change. Prices as of 4/19/2026.

Need Research Supplies?

Syringes, bacteriostatic water, vials, alcohol swabs, and more. Everything you need for peptide research.

Browse Supplies